Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses

European Journal of Immunology

Volumn 36, Issue 8, 2006, Pages 2094-2105

  Fink, Katja ^a   Lang, Karl S ^a   Manjarrez Orduno, Nataly ^a,d   Junt, Tobias ^b   Senn, Beatrice M ^a,e   Holdener, Martin ^a,f   Akira, Shizuo ^c   Zinkernagel, Rolf M ^a   Hengartner, Hans ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e INTERCELL AG   (Austria)

^f LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Antibodies; B cells; Interferons; Plasma cells; TLR

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ANTIVIRUS AGENT; B LYMPHOCYTE RECEPTOR; BETA INTERFERON RECEPTOR; CYTOKINE; IMMUNOGLOBULIN M; INTERFERON; TOLL LIKE RECEPTOR 7;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS TITRATION;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; INTERFERON TYPE I; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 7; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 33747411261     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200635993     Document Type: Article

References (43)

1. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. and Schreiber, R. D., How cells respond to interferons. Annu. Rev. Biochem. 1998. 67: 227-264.
2. Dalod, M., Hamilton, T., Salomon, R., Salazar-Mather, T. P., Henry, S. C., Hamilton, J. D. and Biron, C. A., Dendritic cell responses to early murine cytomegalovirus infection: Subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 2003. 197: 885-898.
3. Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P. and Cerutti, A., DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 2002. 3: 822-829.
4. Pogue, S. L., Preston, B. T., Stalder, J., Bebbington, C. R. and Cardarelli, P. M., The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells. J. Interferon Cytokine Res. 2004. 24: 131-139.
5. Biron, C. A., Interferons alpha and beta as immune regulators - a new look. Immunity 2001. 14: 661-664.
6. Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. and Murali-Krishna, K., Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005. 202: 637-650.
7. Liu, Y. J., IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005. 23: 275-306.
8. Malmgaard, L., Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 2004. 24: 439-454.
9. Kawai, T. and Akira, S., Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 2005. 17: 338-344.
10. Muller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M. and Aguet, M., Functional role of type I and type II interferons in antiviral defense. Science 1994. 264: 1918-1921.
11. Barchet, W., Cella, M., Odermatt, B., Asselin-Paturel, C., Colonna, M. and Kalinke, U., Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J. Exp. Med. 2002. 195: 507-516.
12. Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A. and Flavell, R. A., Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 2004. 101: 5598-5603.
13. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S. and Hartmann, G., Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002. 168: 4531-4537.
14. Bekeredjian-Ding, I. B., Wagner, M., Hornung, V., Giese, T., Schnurr, M., Endres, S. and Hartmann, G., Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 2005. 174: 4043-4050.
15. Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M. et al., CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 2005. 6: 565-570.
16. Kawai, T. and Akira, S., Innate immune recognition of viral infection. Nat. Immunol. 2006. 7: 131-137.
17. Shechter, Y., Preciado-Patt, L., Schreiber, G. and Fridkin, M., Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7-interferon-alpha 2. Proc. Natl. Acad. Sci. USA 2001. 98: 1212-1217.
18. Hangartner, L., Senn, B. M., Ledermann, B., Kalinke, U., Seiler, P., Bucher, E., Zellweger, R. M. et al., Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies. Proc. Natl. Acad. Sci. USA 2003. 100: 12883-12888.
19. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T. et al., Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002. 3: 196-200.
20. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F. and Tough, D. F., Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001. 14: 461-470.
21. Braun, D., Caramalho, I. and Demengeot, J., IFN-alpha/beta enhances BCR-dependent B cell responses. Int. Immunol. 2002. 14: 411-419.
22. Jego, G., Palucka, A. K., Blanck, J. P., Chalouni, C., Pascual, V. and Banchereau, J., Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003. 19: 225-234.
23. Le Bon, A., Thompson, C., Kamphuis, E., Durand, V., Rossmann, C., Kalinke, U. and Tough, D. F., Cutting Edge: Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 2006. 176: 2074-2078.
24. Aichele, P., Zinke, J., Grode, L., Schwendener, R. A., Kaufmann, S. H. and Seiler, P., Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. J. Immunol. 2003. 171: 1148-1155.
25. Oehen, S., Odermatt, B., Karrer, U., Hengartner, H., Zinkernagel, R. and Lopez-Macias, C., Marginal zone macrophages and immune responses against viruses. J. Immunol. 2002. 169: 1453-1458.
26. Balazs, M., Martin, F., Zhou, T. and Kearney, J., Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002. 17: 341.
27. Pape, K. A., Kouskoff, V., Nemazee, D., Tang, H. L., Cyster, J. G., Tze, L. E., Hippen, K. L. et al., Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J. Exp. Med. 2003. 197: 1677-1687.
28. Reif, K., Ekland, E. H., Ohl, L., Nakano, H., Lipp, M., Forster, R. and Cyster, J. G., Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002. 416: 94-99.
29. Ochsenbein, A. F., Pinschewer, D. D., Odermatt, B., Ciurea, A., Hengartner, H. and Zinkernagel, R. M., Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: Implications for splenectomized patients and vaccine design. J. Immunol. 2000. 164: 6296-6302.
30. Fernandez, M., Porosnicu, M., Markovic, D. and Barber, G. N., Genetically engineered vesicular stomatitis virus in gene therapy: Application for treatment of malignant disease. J. Virol. 2002. 76: 895-904.
31. Levy, D. E., Marie, I., Smith, E. and Prakash, A., Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J. Interferon Cytokine Res. 2002. 22: 87-93.
32. Siren, J., Pirhonen, J., Julkunen, I. and Matikainen, S., IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J. Immunol. 2005. 174: 1932-1937.
33. Jego, G., Pascual, V., Palucka, A. K. and Banchereau, J., Dendritic cells control B cell growth and differentiation. Curr. Dir. Autoimmun. 2005. 8: 124-139.
34. Lund, J., Sato, A., Akira, S., Medzhitov, R. and Iwasaki, A., Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 2003. 198: 513-520.
35. Colonna, M., Trinchieri, G. and Liu, Y. J., Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004. 5: 1219-1226.
36. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K. et al., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004. 5: 730-737.
37. Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T. et al., Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005. 23: 19-28.
38. Yang, R., Murillo, F. M., Delannoy, M. J., Blosser, R. L., Yutzy, W. H. T., Uematsu, S. et al., B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88. J. Immunol. 2005. 174: 7912-7919.
39. Takaoka, A., Mitani, Y., Suemori, H., Sato, M., Yokochi, T., Noguchi, S., Tanaka, N. and Taniguchi, T., Cross talk between interferon-gamma and - alpha/beta signaling components in caveolar membrane domains. Science 2000. 288: 2357-2360.
40. Asselin-Paturel, C., Brizard, G., Chemin, K., Boonstra, A., O'Garra, A., Vicari, A. and Trinchieri, G., Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 2005. 201: 1157-1167.
41. Moynagh, P. N., TLR signalling and activation of IRFs: Revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005. 26: 469-476.
42. Taniguchi, T. and Takaoka, A., The interferon-alpha/beta system in antiviral responses: A multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 2002. 14: 111-116.
43. Bachmann, M. F., Odermatt, B., Hengartner, H. and Zinkernagel, R. M., Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 1996. 183: 2259-2269.